Skip to main content
Aman Opneja, MD, Oncology, Raleigh, NC

Aman Opneja MD

Gastrointestinal Cancer


Physician

Join to View Full Profile
  • 3404 Wake Forest RdRaleigh, NC 27609

  • Phone+1 919-862-5400

Dr. Opneja is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Aman Opneja is an oncologist based in Raleigh, NC, specializing in gastrointestinal cancer. He completed his residency in Internal Medicine at Sinai Hospital of Baltimore and a fellowship in Hematology and Medical Oncology at Case Western Reserve University/University Hospitals Cleveland Medical Center. He graduated from Maulana Azad Medical College in 2012. Dr. Opneja currently practices as an oncologist at Duke University since 2023 and previously worked at Alaska Native Medical Center as a hematologist/oncologist from 2019 to 2022. His research contributions include studies on hepatocellular carcinoma, direct oral anticoagulants, and thrombosis, with multiple publications in peer-reviewed journals.

Education & Training

  • Case Western Reserve University/University Hospitals Cleveland Medical Center
    Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
  • Sinai Hospital of Baltimore
    Sinai Hospital of BaltimoreResidency, Internal Medicine, 2013 - 2016
  • Maulana Azad Medical College
    Maulana Azad Medical CollegeClass of 2012

Certifications & Licensure

  • AK State Medical License
    AK State Medical License 2019 - Present
  • NC State Medical License
    NC State Medical License 2022 - 2026
  • OH State Medical License
    OH State Medical License 2016 - 2019
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Lectures

  • The impact of sorafenib on the treatment and survival of advanced hepatocellular carcinoma (HCC): Analysis of the National Cancer Database (NCDB) from 2004 to 2014. 
    2019 ASCO Annual Meeting - 6/1/2019

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: